The Scientist

» pharmaceuticals and developmental biology

Most Recent

image: Gut Bacteria Linked to Asthma Risk

Gut Bacteria Linked to Asthma Risk

By | October 1, 2015

Four types of gut bacteria found in babies’ stool may help researchers predict the future development of asthma.

0 Comments

image: Sex on the Brain

Sex on the Brain

By | October 1, 2015

Masculinization of the developing rodent brain leads to significant structural differences between the two sexes.

1 Comment

image: Sex Differences in the Brain

Sex Differences in the Brain

By | October 1, 2015

How male and female brains diverge is a hotly debated topic, but the study of model organisms points to differences that cannot be ignored.

27 Comments

image: Biotech Stocks Take a Hit

Biotech Stocks Take a Hit

By | September 30, 2015

Some say the biotech bubble has burst over concerns that drug prices are too high—and may soon be regulated.

1 Comment

image: Drug Pricing Incites Outrage

Drug Pricing Incites Outrage

By | September 22, 2015

Will public disgust over dramatic hikes in the cost of medications change industry practices?

0 Comments

image: Whaling Specimens, 1930s

Whaling Specimens, 1930s

By | September 1, 2015

Fetal specimens collected by commercial whalers offer insights into how whales may have evolved their specialized hearing organs.

0 Comments

image: Q&A: Placental Ponderings

Q&A: Placental Ponderings

By | August 27, 2015

Biologist Christopher Coe answers readers’ questions about the prescient organ.

0 Comments

image: TS Live: Pharma Feast

TS Live: Pharma Feast

By | August 26, 2015

A sampling of the biggest acquisitions reshaping the life sciences industry in 2015

0 Comments

image: Novartis Buys Rights to GSK MS Drug for $1 Billion

Novartis Buys Rights to GSK MS Drug for $1 Billion

By | August 24, 2015

The multiple sclerosis treatment has yet to be tested in Phase 3 clinical trials.

0 Comments

image: Valeant Scoops Sprout for $1 Billion

Valeant Scoops Sprout for $1 Billion

By | August 24, 2015

The Canadian pharmaceutical firm is buying the American drugmaker behind the newly approved “female Viagra.”

0 Comments

Popular Now

  1. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  2. Henrietta Lacks’s Family Seeks Compensation
  3. Humans Never Stopped Evolving
    Features Humans Never Stopped Evolving

    The emergence of blood abnormalities, an adult ability to digest milk, and changes in our physical appearance point to the continued evolution of the human race.

  4. Abundant Sequence Errors in Public Databases
Business Birmingham